Maria E. Cabanillas, M.D

Maria E. Cabanillas, M.D

Maria E. Cabanillas, M.D. is an Oncologic Endocrinologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. She is a tenured Professor and the Faculty Director of Clinical Research in the department of Endocrine Neoplasia at MD Anderson.

As a clinician and clinical researcher, she treats both early and advanced thyroid cancers. Her research focus is in advanced and aggressive thyroid cancer, with an emphasis that includes molecular targeted therapies and immunotherapy. Dr. Cabanillas led the effort to create FAST, Facilitating Anaplastic thyroid cancer Specialized Treatment at MD Anderson–a multidisciplinary group who sees the highest volume of anaplastic thyroid cancer patients in the nation. In 2022 she was the recipient of the Beverly and Jack Randall Prize for Cancer Treatment for this comprehensive and innovative treatment program for anaplastic thyroid cancer, which led to a nearly 3-fold improvement in overall survival for these patients.

Dr. Cabanillas serves as the principal investigator on several clinical trials for the treatment of advanced thyroid cancer and completed her service on the 2021 anaplastic thyroid cancer guidelines committee for the American Thyroid Association. She has been a member of the International Thyroid Oncology Group (ITOG) since 2012 and completed her term on the Board of Directors in 2020.